• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Mark Egerton - Articles and news items

Quotient-clinical-logo

Sunesis Pharmaceuticals selects Quotient Clinical’s real-time adaptive manufacturing to support its vosaroxin clinical mass balance/ADME program

Supplier news / 21 January 2015 / kdm communications

Quotient Clinical, the Translational Pharmaceutics® Company, and Sunesis Pharmaceuticals have announced the initiation of a clinical mass balance/ADME trial for vosaroxin – a candidate therapeutic for acute myelogenous leukemia (AML)…

Quotient Clinical

Quotient Clinical extends its Translational Pharmaceutics™ platform into cancer drug development

Supplier news / 7 May 2014 / kdm communications

Quotient Clinical has announced the extension of its Translational Pharmaceutics™ platform into patient-focused cancer drug development…

Quotient Clinical

Quotient Clinical celebrates its 50th RapidFACT™ program

Supplier news / 7 February 2014 / kdm communications

Quotient Clinical has commenced its 50th RapidFACT (Rapid Formulation development And Clinical Testing) program – a significant milestone in the development of this service…

Quotient Clinical

Bridgepoint Development Capital to acquire Quotient Clinical

Supplier news / 11 December 2013 / KDM Communications

Quotient Clinical has been acquired from the Quotient Bioresearch Group by Bridgepoint Development Capital for an undisclosed sum…

Quotient-clinical-logo

Quotient Clinical announces major expansion of its GMP manufacturing and formulation development capacity

News, Supplier news / 3 March 2011 / The Scott Partnership

To accommodate demand for its RapidFACT Service…

Quotient Clinical and Bend Research Announce Collaboration To Accelerate Advancement of New Medicines

News, Supplier news / 10 November 2010 / The Scott Partnership

Speeding the advance of compounds to clinical trials and expanding options for drug delivery…

Quotient Bioresearch Highlight Integrated Early Stage Drug Development Platforms

News, Supplier news / 12 October 2010 / The Scott Partnership

Quotient Bioresearch, will be highlighting integrated early stage drug development platforms at FIP Pharmaceutical Sciences World Congress…

 

Webinar: Different thermal analysis techniques to measure the glass transitionWATCH NOW
+ +